Carcinoma Neuroendocrine
📧 Sign up to get email alerts when something new happens for Carcinoma Neuroendocrine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types [Phase 2]
Phase 2 trial update indicating access to pembrolizumab for selected rare cancer types has been secured.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis [Phase 1, Phase 2]
An open-label pilot study evaluating everolimus with external beam radiotherapy for neuroendocrine tumor liver metastases has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery [Phase 2]
Phase 2 trial evaluating mutation-targeted therapy with sunitinib or everolimus in advanced low- or intermediate-grade neuroendocrine tumors…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors [Phase 2]
Phase 2 clinical trial update for KPT-330 targeting poorly differentiated lung and gastroenteropancreatic tumors has completed.